RDY
Dr. Reddy's Laboratories Ltd. Earnings
$14.13
Earnings Summary
Revenue | $85452Mn |
Net Profits | $14178Mn |
Net Profit Margins | 16.59% |
Dr. Reddy's Laboratories Ltd.’s revenue jumped 11.37% since last year same period to $85452Mn in the Q2 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 0.46% jump in its revenue since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit jumped 1.85% since last year same period to $14178Mn in the Q2 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -11.04% fall in its net profits since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit margin fell -8.55% since last year same period to 16.59% in the Q2 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -11.45% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.23 |
EPS Estimate Current Year | 0.23 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.23 - a 7.19% jump from last quarter’s estimates.
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.23.
Key Ratios
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.19 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Dr. Reddy's Laboratories Ltd. declared 0.19 dividend per share during the earnings announcement for Q3 2025.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-06-30 | 0.21 | 0.2 | -4.76% |
2025-06-06 | 0.21 | 0.22 | 4.76% |
2025-10-24 | 0.23 | 0 | -100% |
